ALUMIS INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Phone
650-231-6625
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$243.32M
Net Income
$411.94M
Total Assets
$110.64M
Total Liabilities
$301.30M
Stockholders' Equity
$169.53M
Cash & Equivalents
$-2.86
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| 5 Annual insider ownership changes | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 28, 2026 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Successfully completed its Initial Public Offering (IPO) on September 15, 2024, becoming a public company.
- Raised a significant $175 million in 2024 through its IPO and subsequent private sales, providing substantial capital for growth.
Insider Trading
STRONG BUY
4 insiders
35 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.